The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation

We describe the response of imatinib as lifesaving treatment of chronic myeloid leukemia (CML) relapse in seven patients who underwent allogeneic bone marrow transplantation (alloBMT) at our institution over a period of 4 years. Retrospective analysis of their medical records revealed that a mean ag...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Conchon, Monika, Sanabani, Sabri S., Bendit, Israel, Dinardo, Carla Luana, Dias, Lucia, Chamone, Dalton de Alencar Fischer, Dorlhiac-Llacer, Pedro Enrique, Dulley, Frederico Luiz
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2009
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809434/
https://ncbi.nlm.nih.gov/pubmed/20107580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/357093
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars